4//SEC Filing
ZETA ACQUISITION CORP III 4
Accession 0001209191-15-024827
$KURACIK 0001422143operating
Filed
Mar 9, 8:00 PM ET
Accepted
Mar 10, 6:15 PM ET
Size
5.4 KB
Accession
0001209191-15-024827
Insider Transaction Report
Form 4
KINLEY MATTHEW P
DirectorSecretary, CFO10% Owner
Transactions
- Disposition to Issuer
Common Stock, par value $0.0001 per share
2015-03-06−2,000,000→ 0 total
Footnotes (1)
- [F1]On March 6, 2015, Kura Oncology, Inc. (formerly Zeta Acquisition Corp. III) (the "Issuer") and the stockholders of the Issuer (the "Sellers") entered into a Redemption Agreement (the "Agreement"). Pursuant to the Agreement, the Issuer re-purchased and redeemed from Mr. Kinley 2,000,000 shares of Common Stock (the "Shares") for a purchase price equal to twenty-eight thousand dollars ($28,000). The purchase and sale of the Shares took place at a closing on March 6, 2015 immediately following the effectiveness of the merger transaction (the "Merger") contemplated by the Agreement and Plan of Merger, dated March 6, 2015, among the Issuer, Kura Oncology, Inc, and Kura Operations, Inc., a wholly-owned subsidiary of the Issuer.
Documents
Issuer
ZETA ACQUISITION CORP III
CIK 0001422143
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001422143
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 8:00 PM ET
- Accepted
- Mar 10, 6:15 PM ET
- Size
- 5.4 KB